Global HIV News

Prevention 08/02/2010

GeoVax Labs, Inc. begins enrollment at final site for preventative vaccine

Next step is to submit IND application for therapeutic vaccine to FDA.

Access to treatment 08/02/2010

Putin sacks Russian drugs law critic

Russian Prime Minister Vladimir Putin has sacked a senior health official for publicly criticising controversial new draft legislation to introduce state regulation of drug pricing.

Access to treatment 08/02/2010

Price rises "will drive US drug spend to $457.8 billion by 2019"

US prescription drug spending is estimated to have grown 5.2% to $246.3 billion in 2009, a two percentage point rise over 2008 which was due to increased per person usage of medicines and higher price growth for brand-name drugs, say new government figure.

Tuberculosis & Malaria 08/02/2010

Breakthrough research could lead to new potential treatments for malaria

"The wealth of new information arising from our extensive four-year study is a major contribution to the worldwide effort to better understand and treat malaria."

Treatment 08/02/2010

Less resistance with FTC than 3TC when combined with tenofovir

Amongst patients experiencing a rebound in viral load, those taking 3TC (lamivudine, Epivir) in combination with tenofovir (Viread) were more likely than those taking FTC (emtricitabine, Emtriva) and tenofovir to develop a number of key resistance mutations.

Treatment 05/02/2010

Medication-assisted treatment of drug and alcohol abuse and dependence for people with HIV

Injection drug users and alcoholics often receive a late diagnosis of HIV and thus have more advanced disease and poorer outcomes than other groups of HIV positive patients.

Prevention 05/02/2010

Positive Prevention guide

A guide developed by the Family Planning Association of India (FPA India), and the Indian Network of People living with HIV (INP+) with support from the International Planned Parenthood Federation (IPPF) Central Office and South Asia Regional Office.

EU Policy 05/02/2010

EC changes on running pharma must not be cosmetic – DTB

A leading journal has expressed caution about the management of pharmaceutical policy being transferred from the European Commission’s Enterprise and Industry directorate to Health and Consumer Policy (DG SANCO) and criticised the latest pharmacovigilance proposals.

Print